cancer
Researchers identified 36 bacterial species, particularly Hungatella hathewayi and Intestinimonas butyriciproducens, associated with colorectal cancer.
Francesca Ponziani from Gemelli University Hospital (Italy) highlights how the gut microbiota can become a clinical tool for identifying and stratifying patients, clarifying pathogenic mechanisms, and opening up new therapeutic…
Certain harmful microbes in the mouth appear to promote cancer development, while others might help protect against it.
Federica Facciotti, from University of Milano Bicocca, focuses on how the gut microbiota interacts with immune activation, shaping both chronic inflammatory intestinal disorders and oncology, particularly colorectal cancer.
Diet and gut microbes can shape immune cell function and improve responses to anti-cancer therapy.
Results of a recent study showed reduced microbial diversity and distinct microbial profile in the two groups of PC patients.
Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.
Targeting gut bacteria or butyrate could be a promising therapy for glioma.
Three promising bacteria were linked to better treatment responses in melanoma patients.
A recent study highlights formate as a potential target to boost cancer treatment.
